Brief: Axovant Provides Business, Operations Update During Covid-19 Pandemic

Sio Gene Therapies

08/04/2020 13:13

April 8 (Reuters) - Axovant Gene Therapies Ltd  AXGT.O :
    * AXOVANT PROVIDES BUSINESS AND OPERATIONS UPDATE DURING THE
COVID-19 PANDEMIC
    * AXOVANT GENE THERAPIES LTD - COMPLETED DOSING OF ALL
PATIENTS IN
SECOND COHORT OF AXO-LENTI-PD DOSE ESCALATION STUDY
    * AXOVANT GENE THERAPIES LTD - ARE ON TRACK TO ATTAIN OUR
2020
MILESTONES
    * AXOVANT GENE THERAPIES LTD - AXOVANT HAS MATERIAL FOR
LENTIVIRAL
AND AAV PROGRAMS ON HAND TO MEET NEEDS OF OUR ONGOING CLINICAL
TRIALS
    * AXOVANT GENE THERAPIES LTD - PLANS TO UPDATE ITS GUIDANCE
IN
JUNE 2020 WHEN COMPANY ANNOUNCES FISCAL 2019 YEAR-END RESULTS

Source text for Eikon:  ID:nGNXBC0C5 
Further company coverage:  AXGT.O 

 ((Reuters.Briefs@thomsonreuters.com;))